Finance
Medical
Sports

Organogenesis

$6.40
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (1.43%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Organogenesis and other stocks, options, ETFs, and crypto commission-free!

About ORGO

Organogenesis Holdings Inc. Class A Common Stock, also called Organogenesis, is a regenerative medical company. Read More It focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.

Employees
700
Headquarters
Canton, Massachusetts
Founded
1985
Market Cap
576.20M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
66.20K
High Today
$6.77
Low Today
$6.30
Open Price
$6.77
Volume
52.07K
52 Week High
$310.90
52 Week Low
$6.28

Collections

Finance
Medical
Sports
Health
Entertainment
2016 IPO
US
North America

ORGO Earnings

Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Aug 9, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.